A Randomized Open Label Mechanistic Study in Atopic Dermatitis to Assess the Immunogenicity of Fluzone Intradermal and Intramuscular Vaccines

Trial Profile

A Randomized Open Label Mechanistic Study in Atopic Dermatitis to Assess the Immunogenicity of Fluzone Intradermal and Intramuscular Vaccines

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 23 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 10 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 10 May 2013 Planned end date changed from 1 Mar 2013 to 1 May 2013 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top